New study aims to end guesswork in sleep apnea implant success

NCT ID NCT05429983

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at 60 people with moderate to severe sleep apnea who are being evaluated for a nerve stimulator implant (Inspire). During a routine sleep endoscopy, researchers will measure how the airway responds to direct muscle stimulation. They want to see if these measurements can predict who will have a good response to the implant, defined as a 50% reduction in apnea events. The goal is to improve patient selection and avoid implanting the device in people who won't benefit.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
hypoglossal nerve stimulation device (Inspire)
What this could lead to
If successful, this could help doctors better predict which sleep apnea patients will benefit from the Inspire device, reducing the number of people who get the implant but don't improve.
What could go wrong
This is an early-stage observational study with only 60 participants. The measurements may not reliably predict outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP APNEA, OBSTRUCTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins Hospital

    RECRUITING

    Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.